HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

interleukin 13 antagonist E13K

an IL13 recombinant mutant where Glu position 13 is substituted by Lys

Also Known As:

IL-13E13K

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Interleukins: 25257
        Interleukin-13: 5629
        interleukin 13 antagonist E13K: 3
- Peptides: 82426
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Interleukins: 25257
        Interleukin-13: 5629
        interleukin 13 antagonist E13K: 3
Biological Factors: 2472
- Intercellular Signaling Peptides and Proteins: 29768
  - Cytokines: 164289
    - Interleukins: 25257
      - Interleukin-13: 5629
        interleukin 13 antagonist E13K: 3

Experts

1.	Oshima, Y: 2 articles (07/2001 - 05/2001)
2.	Puri, R K: 2 articles (07/2001 - 05/2001)
3.	Kawakami, Koji: 1 article (05/2004)
4.	Kioi, Mitomu: 1 article (05/2004)
5.	Puri, Raj K: 1 article (05/2004)

Related Diseases

1.	Neoplasms (Cancer) 05/04/2001 - "These results also suggest that IL-13E13K may be a useful antagonist for the treatment of allergic, inflammatory, and parasitic diseases or even malignancies in which IL-13 plays a central role." 05/01/2004 - "Thus, IL-13E13K may be a useful agent for the treatment of diseases such as asthma, allergic rhinitis, and cancer, which are dependent on signaling through both IL-4 and IL-13 receptors."
2.	Allergic Rhinitis 05/01/2004 - "Thus, IL-13E13K may be a useful agent for the treatment of diseases such as asthma, allergic rhinitis, and cancer, which are dependent on signaling through both IL-4 and IL-13 receptors."
3.	Parasitic Diseases (Parasitic Disease) 05/04/2001 - "These results also suggest that IL-13E13K may be a useful antagonist for the treatment of allergic, inflammatory, and parasitic diseases or even malignancies in which IL-13 plays a central role."
4.	Hodgkin Disease (Hodgkin's Disease) 07/10/2001 - "Since we have recently identified and produced a novel IL-13 antagonist (IL-13E13K) that can suppress the biological activity of IL-13, here we examined whether IL-13E13K can inhibit growth of Hodgkin lymphoma (HL)-derived cell lines. "
5.	Asthma (Bronchial Asthma) 05/01/2004 - "Thus, IL-13E13K may be a useful agent for the treatment of diseases such as asthma, allergic rhinitis, and cancer, which are dependent on signaling through both IL-4 and IL-13 receptors."

Related Drugs and Biologics

1.	Interleukin-13
2.	Interleukin-13 Receptors (Interleukin 13 Receptor)
3.	Interleukin-4 (Interleukin 4)